---
title: Common and complex diseases
description: Short text describing this use case
page_id: common-complex-diseases
---
## Common and complex diseases and pharmacogenomics: 

You can find the policy brief for 2022-2027 [here](https://ec.europa.eu/newsroom/dae/redirection/document/93728).

In each population, individualsâ€™ genetic variants can be used to calculate polygenic risk scores (PRS) to help predict personal increased/decreased risk for developing many common diseases and can be used for pharmacogenomic (PGx) purposes by predicting drug toxicity and effectiveness and also vaccine safety. 

In this brief, four actions are recommended by signatory countries.



**We are still working on the content for this page.** If you are interested in adding to the page, then:

[Feel free to contribute](how_to_contribute){: class="btn btn-primary btn-lg rounded-pill"}

This is a community-driven website, so contributions are welcome! You will, of course, be listed as a contributor on the page.